PRAX NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Praxis Precision Medicines Inc · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 325.3 USD
3.5% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is 3.4% above the Trend Line and sits at 87.5% of its 52-week range. The latest completed week returned 3.5%, after a -0.8% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 59/100 conviction, while the latest news-sentiment score is 55/100. Near-term considerations: volume confirmation is below normal; earnings are due in 2d.

Setup score 52 out of 100
Latest Close 325.3 USD 24 Jul 2026
1W Return 3.5% latest completed week
4W Return -0.8% short-term follow-through
12W Return 0.3% quarterly tape
Trend Breadth 76.9% 40 of 52 weeks active
Volume Ratio 0.6x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Next-week expectancy is positive at 57.37% based on similar historical setup states.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Activity pressure is negative, which weakens the current setup.
  • 11 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 3.5% Latest completed week; four-week move -0.8%. Indicator stack 42/38 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 57.37% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Volatility 59/100 conviction; expected move 13.2%. News sentiment 55/100 61 relevant articles in the latest sentiment read. Event risk 2d Next report is scheduled for 03 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 3.4% above the Trend Line and sits at 87.5% of its 52-week range. The latest completed week returned 3.5%, after a -0.8% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.7012-week average 0.72

12-week confirmation

Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.70Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers1111 reversal markers

No recent accumulation markers. 11 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -0.8% over four weeks, 0.3% over 12 weeks, and 449.3% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W3.5%
4W-0.8%
12W0.3%
26W4.4%
52W449.3%
Active trend streak0 weeks
Active weeks in one year40
Trend breadth76.9%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.72Latest activity-pressure read.
Pressure change16.5%Four-week change in activity pressure.
Leadership28.39Latest relative-leadership reading.
RS change-19.9%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 67% Model confidence 64%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength43/100Blend of value, momentum, and quality. Underlying universe rank 58; rank 1 is best.
Value46/100Relative valuation strength. Underlying universe rank 55; rank 1 is best.
Quality45/100Profitability and accounting quality. Underlying universe rank 56; rank 1 is best.
Momentum47/100Medium-term price momentum. Underlying universe rank 54; rank 1 is best.
Growth47/100Revenue and earnings growth. Underlying universe rank 54; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
-
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-3.3%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-
Gross profit retained from each unit of revenue.
Operating margin
-
Operating profit retained from revenue.
Free-cash-flow margin
-
Free cash flow generated from revenue.
Return on invested capital
-28.0%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-13.9%
Net share repurchases relative to market value.
Shareholder yield
-13.9%
Dividend yield plus net buyback yield.
Net debt / EBITDA
1.6x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

PRAX shows volatility options pressure with a 59/100 conviction score, put-call volume ratio of 3.19, expected move of 13.2%, and Sharemaestro trend signal inactive.

Conviction59/100
Expected move13.2%
Put/call volume3.19
Pressure-64
Speculation32
Volatility95
Trend agreement58
Open options detail
Insider activity4 / 16

4 acquisitions and 16 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment55/100

Weighted news tone is neutral across 61 relevant articles.

23 positive · 33 neutral · 5 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings2dNext report is scheduled for 03 Aug 2026; event risk rises as the date approaches.
Options expected move13.2%Nearest-chain priced movement where available.
52-week drawdown-11.2%Distance below the 52-week high.
13-week volatility9.5%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher18 of 268 weeks finished lower.
Best week+16.1%Week of 26 Jun.
Worst week-27.4%Week of 5 Jun.
Latest week+3.5%Week of 24 Jul.

Shape of recent returns

Strong gains6
Modest gains12
Flat weeks0
Modest losses4
Sharp losses4
Recent vol9.5%13-week weekly-return volatility.
Base vol36.3%52-week weekly-return volatility.
Up/down split34/18Count of positive and negative weeks in the 52-week window.
Average skew13.8% / -8.0%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape53/100

Trend, activity pressure, participation, and risk combine to a 53/100 tape read.

 Indicator analysis42/100

Latest 12-week confirmation: trend 5/12, activity pressure 0/12, relative leadership 12/12.

Activity pressure 0.70; 11 reversal markers Next-Week ExpectancyPositive 57.37%

Next-week expectancy is positive with a 57.37% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors44/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 89; Small Cap Core rank 56 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options54/100

PRAX shows volatility options pressure with a 59/100 conviction score, put-call volume ratio of 3.19, expected move of 13.2%, and Sharemaestro trend signal inactive.

Volatility · Volatility expansion watch · Expected move 13.2% Sentiment55/100

Weighted news tone is neutral across 61 relevant articles.

Praxis Precision Medicines Inc (PRAX) Financial Health: Profitability & Balance Sheet Analysis Insiders4 / 16

4 acquisitions and 16 disposals in the latest 180-day insider tape.

 Earnings2d

Next report is scheduled for 03 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 2026325.3 USD3.5%314.6 USD109.6 USD-0.7228.391.3MOff
17 Jul 2026314.4 USD-3.3%312.7 USD107.6 USD-0.5424.511.5MOff
10 Jul 2026325.0 USD2.0%311.3 USD105.7 USD-0.5825.712.3MOff
3 Jul 2026318.5 USD-2.8%309.5 USD103.7 USD-0.7427.902.5MOff
26 Jun 2026327.8 USD16.1%307.1 USD101.8 USD-0.8635.454.7MOff
19 Jun 2026282.3 USD5.9%302.7 USD99.77 USD-0.9513.872.2MOff
12 Jun 2026266.6 USD5.0%299.0 USD98.07 USD-0.8112.342.5MOff
5 Jun 2026254.0 USD-27.4%296.3 USD96.46 USD-0.5711.374.2MOn
29 May 2026350.0 USD1.9%293.4 USD94.93 USD-0.4548.981.3MOn
22 May 2026343.6 USD0.3%288.4 USD92.78 USD-0.4654.211.4MOn
15 May 2026342.6 USD3.8%282.8 USD90.68 USD-0.4659.642.2MOn
8 May 2026330.0 USD1.8%277.7 USD88.58 USD-0.4457.411.9MOn
1 May 2026324.2 USD-6.0%268.4 USD86.56 USD-0.5067.342.3MOn
24 Apr 2026344.8 USD0.7%259.4 USD84.59 USD-0.5685.691.6MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.